152 related articles for article (PubMed ID: 31222839)
1. Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.
Sai E; Miwa Y; Takeyama R; Kojima S; Ueno T; Yashiro M; Seto Y; Mano H
Cancer Sci; 2019 Aug; 110(8):2643-2651. PubMed ID: 31222839
[TBL] [Abstract][Full Text] [Related]
2. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract][Full Text] [Related]
3. Candidate Oncogenes,
Sera T; Sakuma T; Maruo K; Tsujio G; Yamamoto Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Kasashima H; Ohira M; Maeda K
Anticancer Res; 2022 Nov; 42(11):5195-5203. PubMed ID: 36288877
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic MAP2K1 mutations in human epithelial tumors.
Choi YL; Soda M; Ueno T; Hamada T; Haruta H; Yamato A; Fukumura K; Ando M; Kawazu M; Yamashita Y; Mano H
Carcinogenesis; 2012 May; 33(5):956-61. PubMed ID: 22327936
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14.
Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M
Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.
Kato Y; Yashiro M; Noda S; Tendo M; Kashiwagi S; Doi Y; Nishii T; Matsuoka J; Fuyuhiro Y; Shinto O; Sawada T; Ohira M; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):898-907. PubMed ID: 20145613
[TBL] [Abstract][Full Text] [Related]
9. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
[TBL] [Abstract][Full Text] [Related]
10. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
Yashiro M; Matsuoka T; Ohira M
Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
12. Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells.
Kuramitsu Y; Baron B; Yoshino S; Zhang X; Tanaka T; Yashiro M; Hirakawa K; Oka M; Nakamura K
Anticancer Res; 2010 Nov; 30(11):4459-65. PubMed ID: 21115893
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus.
Murahashi K; Yashiro M; Takenaka C; Matsuoka T; Ohira M; Chung KH
Int J Oncol; 2001 Nov; 19(5):1029-33. PubMed ID: 11605005
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
[TBL] [Abstract][Full Text] [Related]
16. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells.
Kushiyama S; Yashiro M; Yamamoto Y; Sera T; Sugimoto A; Nishimura S; Togano S; Kuroda K; Okuno T; Miki Y; Ohira M
Anticancer Res; 2022 Jan; 42(1):501-509. PubMed ID: 34969760
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.
Fuyuhiro Y; Yashiro M; Noda S; Kashiwagi S; Matsuoka J; Doi Y; Kato Y; Hasegawa T; Sawada T; Hirakawa K
Br J Cancer; 2011 Sep; 105(7):996-1001. PubMed ID: 21863023
[TBL] [Abstract][Full Text] [Related]
19. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.
Fujihara T; Sawada T; Hirakawa K; Chung YS; Yashiro M; Inoue T; Sowa M
Clin Exp Metastasis; 1998 May; 16(4):389-98. PubMed ID: 9626818
[TBL] [Abstract][Full Text] [Related]
20. Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.
Namiki Y; Namiki T; Yoshida H; Date M; Yashiro M; Matsumoto K; Nakamura T; Yanagihara K; Tada N; Satoi J; Fujise K
Int J Cancer; 2006 Mar; 118(6):1545-55. PubMed ID: 16206271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
